CDK9 Antikörper (N-Term)

Produktnummer ABIN926890

Dieser Kaninchen Polyklonal Antikörper detektiert spezifisch CDK9 in WB. Es zeigt Reaktivität gegenüber Proben von Human.

Kurzübersicht für CDK9 Antikörper (N-Term) (ABIN926890)

Target: CDK9 (Cyclin-Dependent Kinase 9 (CDK9))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CDK9 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-CDK9 Antikörper

Bindungsspezifität: N-Term

Aufreinigung: Purified

Immunogen: CDK9 antibody was raised in rabbit using the N terminal of CDK9 as the immunogen

Anwendungsinformationen

Applikationshinweise: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu CDK9

Target: CDK9 (Cyclin-Dependent Kinase 9 (CDK9))

Andere Bezeichnung: CDK9

Hintergrund: CDK9 is the member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to production elongation by phosphorylating the CTD of the large subunit of RNA polymerase II (RNAP II), SUPT5H and RDBP. The CDK9/cyclin-K complex has also a kinase activity toward CTD of RNAP II and can substitute for P-TEFb in vitro. Synonyms: Polyclonal CDK9 antibody, Anti-CDK9 antibody, cyclin-dependent kinase 9 antibody, C-2k antibody, CDC2L4 antibody, PITALRE antibody, TAK antibody.

Pathways: Zellzyklus